The role of PHF6 in the control of hematopoietic stem cell aging.
The role of PHF6 in the control of hematopoietic stem cell aging.
批准号:
10474570
负责人:
Teresa Palomero
金额:
$50.0万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-01 至 2026-05-31
关键词:
AgeAgingAnabolismAnimal ModelBiological AssayBone MarrowCell AdhesionCell AgingCell CompartmentationCell CycleCell Cycle KineticsCell NucleolusCell ProliferationCell divisionCell modelCell physiologyCellsChromatinClustered Regularly Interspaced Short Palindromic RepeatsColony-Forming Units AssayComplexComputational BiologyDNA DamageDeacetylaseDeteriorationDevelopmentEngraftmentEpigenetic ProcessEventGenerationsGenesGeneticGenetic TranscriptionGoalsHealthHematopoiesisHematopoieticHematopoietic SystemHematopoietic stem cellsHomingHumanImpairmentIn VitroInflammationInflammatoryKnock-outKnockout MiceLife ExpectancyLymphoidMediatingMediator of activation proteinMetabolismMolecularMyelogenousNucleosomesOrganPathologyPhenotypePlantsPlayPopulationPopulation DecreasesPositioning AttributeProteinsRegulationRibosomesRoleSomatic MutationTestingTherapeutic InterventionTranslationsTransplantationagedanalytical toolcell agecell motilityconditional knockoutcytokineepigenomicsexhaustexperimental studyfitnessfunctional declinegenome integrityhematopoietic stem cell aginghematopoietic stem cell self-renewalhomeodomainimprovedin vivoleukemic transformationnew therapeutic targetprogramsreplication stressresponseself-renewalsenescencestemstem cell agingstem cell functionstem cellstherapeutic developmenttranscriptomics
中文摘要
项目概要/摘要
随着预期寿命的增加,与年龄相关的疾病已成为主要的健康问题。
现在人们认识到干细胞衰老是系统和器官特异性功能的驱动因素
下降。在造血系统中,干细胞衰老的特点是积累
自我更新受损的免疫表型定义的造血干细胞 (HSC)
随着髓系细胞群生成的增加,能力和分化程序发生改变
和淋巴潜能降低。在这里,我们展示了植物同源域的遗传丢失
因子 6 (PHF6) 导致 HSC 连续移植能力增加并消除
与年龄相关的造血衰退的发展,包括功能性造血功能的积累
耗尽的 HSC 表现出骨髓分化偏向和淋巴潜能受损。我们的
中心假设是 Phf6 的缺失会重新配置 HSC 的表观遗传景观
与年龄相关的功能衰退的开始和/或进展。在这里我们将应用
费兰多和拉巴丹实验室在造血和计算方面的综合专业知识
生物学深入探索PHF6失活的造血表型和机制
在 HSC 老化中。为了实现这一目标,我们将分析 Phf6 条件下的干细胞区室
基因敲除小鼠和 CRISPR 指导的 PHF6 失活后的人类造血干细胞
细胞,利用体外和体内干细胞测定结合先进的
应用于单细胞转录组学和表观基因组学的计算分析工具。这些
研究最终将促进新的靶向疗法的开发,旨在改善
老年捐献者造血干细胞的植入能力以及用于治疗
与年龄相关的 HSC 恶化导致的病理。
英文摘要
Project Summary/Abstract
As life expectancy increases age-associated pathologies have become a major health problem.
It is now recognized that stem cell aging is a driver of systemic and organ-specific functional
decline. In the hematopoietic system stem cell aging is characterized by accumulation of
immunophenotypically-defined hematopoietic stem cells (HSCs) with impaired self-renewal
capacity and altered differentiation programs with increased generation of myeloid populations
and decreased lymphoid potential. Here we show that genetic loss of Plant Homeodomain
Factor 6 (PHF6) results in increased HSC serial transplantation capacity and abrogates the
development of age-associated hematopoietic decay including the accumulation of functionally
exhausted HSCs displaying myeloid differentiation bias and impaired lymphoid potential. Our
central hypothesis is that loss of Phf6 reconfigures the epigenetic landscape of HSCs blocking
the initiation and/or progression of age-associated functional decline. Here we will apply the
combined expertise of the Ferrando and Rabadan labs in hematopoiesis and computational
biology to explore in depth the hematopoietic phenotypes and mechanisms of PHF6 inactivation
in HSC aging. Towards this goal we will analyze the stem cell compartment in Phf6 conditional
knockout mice and after CRISPR-directed PHF6 inactivation in human hematopoietic stem
cells, leveraging in vitro and in vivo stem cell assays in combination with advanced
computational analytical tools applied to single cell transcriptomics and epigenomics. These
studies will ultimately facilitate the development of new targeted therapies aimed at improving
the engraftment capacity of hematopoietic stem cells from aged donors and for the treatment of
pathologies resulting from age-associated HSC deterioration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role and Mechanisms of VAV1 alterations in Peripheral T-cell Lymphomas
-
批准号:10317831
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2021
-
负责人:Teresa Palomero
-
依托单位:
Role and Mechanisms of VAV1 alterations in Peripheral T-cell Lymphomas
-
批准号:10622616
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2021
-
负责人:Teresa Palomero
-
依托单位:
Role and Mechanisms of VAV1 alterations in Peripheral T-cell Lymphomas
-
批准号:10438898
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2021
-
负责人:Teresa Palomero
-
依托单位:
The role of PHF6 in the control of hematopoietic stem cell aging.
-
批准号:10656456
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2021
-
负责人:Teresa Palomero
-
依托单位:
Single-cell characterization of tumor and microenvironment co-evolution in Peripheral T-cell Lymphomas
-
批准号:10218124
-
项目类别:
-
资助金额:$60.75万
-
财政年份:2019
-
负责人:Teresa Palomero
-
依托单位:
Single-cell characterization of tumor and microenvironment co-evolution in Peripheral T-cell Lymphomas
-
批准号:10675452
-
项目类别:
-
资助金额:$57.69万
-
财政年份:2019
-
负责人:Teresa Palomero
-
依托单位:
Single-cell characterization of tumor and microenvironment co-evolution in Peripheral T-cell Lymphomas
-
批准号:10449328
-
项目类别:
-
资助金额:$59.53万
-
财政年份:2019
-
负责人:Teresa Palomero
-
依托单位:
The role of RHOA G17V mutation in peripheral t-cell lymphomas
-
批准号:9298610
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2015
-
负责人:Teresa Palomero
-
依托单位:
The role of RHOA G17V mutation in peripheral t-cell lymphomas
-
批准号:9100708
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2015
-
负责人:Teresa Palomero
-
依托单位:
The role of RHOA G17V mutation in peripheral t-cell lymphomas
-
批准号:8946177
-
项目类别:
-
资助金额:$36.6万
-
财政年份:2015
-
负责人:Teresa Palomero
-
依托单位:
海外基金